News
We have seen 2 institutional investors add shares of EVAXION BIOTECH stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback